Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002322845 | SCV002608177 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-04-13 | criteria provided, single submitter | clinical testing | The c.1132_1133delGA pathogenic mutation, located in coding exon 7 of the MSH2 gene, results from a deletion of two nucleotides at nucleotide positions 1132 to 1133, causing a translational frameshift with a predicted alternate stop codon (p.E378Rfs*10). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |